News

2026-03-12

Material Information- The Board of Directors Approved the 2025 Consolidated Financial Statements

1.Date of the board of directors submitted or approved:2026/03/12 2.Date of the audit committee approved:2026/03/12 3.Start and end dates of financial reports or unaudited financial information of the reporting period(XXXX/XX/XX~XXXX/XX/XX):2025/01/01~2025/12/31 4.Operating revenue accumulated from 1/1 to end of the period (thousand NTD):1,729,252 5.Gross profit (loss) from operations accumulated from

2026-05-07

Material Information- Announcement of the Board’s Resolution to redeem and cancel restricted employee shares for a capital reduction

1.Date of the board of directors resolution:2026/05/07 2.Reason for capital reduction:Restricted shares granted to employees who fail to meet the vesting conditions will be redeemed without consideration and canceled for capital reduction in accordance with the issuance rules. 3.Amount of capital reduction:NTD 12,000 4.Cancelled shares:1,200 shares 5.Capital reduction ratio:0.0007% 6.Share

2026-05-07

Material Information- Announcement of the Board of Directors approved the consolidated financial statements for 2026 Q1.

1.Date of the board of directors submitted or approved:2026/05/07 2.Date of the audit committee approved:2026/05/07 3.Start and end dates of financial reports or unaudited financial information of the reporting period(XXXX/XX/XX~XXXX/XX/XX):2026/01/01~2026/03/31 4.Operating revenue accumulated from 1/1 to end of the period (thousand NTD):209,615 5.Gross profit (loss) from operations accumulated from

2026-04-29

Material Information- Announcement of the expected date of the Board Meeting to approve 2026 Q1 Financial Report on May 7, 2026

1.Date of a notice of the board of directors meeting is issued:2026/04/29 2.Expected date of the board of directors meeting is convened:2026/05/07 3.Expected year and quarter of the financial reports or the annual self-assessed financial information submitted to the board of directors or approved by the board

2026-04-19

Material Information- Announces on behalf of the subsidiary Handa Oncology, LLC, regarding the 505(b)(2) new formulation drug HND-039 citizen petition to the FDA examination

1.Date of occurrence of the event:2026/04/17 2.Company name:Handa Oncology, LLC 3.Relationship to the Company (please enter ”head office” or ”subsidiaries”):Subsidiaries 4.Reciprocal shareholding ratios:Not applicable 5.Cause of occurrence:The Company was informed on April 16, 2026 (U.S. time) that Handa Oncology, LLC (hereinafter referred to as “Handa Oncology”),an indirectly held subsidiary

2026-04-16

Material Information- Announcement of the Board’s Resolution to Repurchase Treasury Shares

1.Date of the board of directors resolution:2026/04/16 2.Purpose of the share repurchase:To maintain the Company’s credit and shareholders’ equity. 3.Type of shares to be repurchased:Common shares 4.Ceiling on total monetary amount of share repurchase (NTD):3,724,664,099 5.Scheduled period for the repurchase:2026/04/17~2026/06/16 6.No.of shares to be repurchased (shares):4,000,000 7.Repurchase price range (NTD):70.00~109.00, should

2026-03-31

Material Information- Announcement of the Completion of the Company’s Treasury Share Buyback

1.Originally prescribed ceiling on total monetary amount of share repurchase (NTD):3,087,249,414 2.Originally scheduled period for the repurchase:2026/02/12~2026/04/11 3.Originally determined no.of shares to be repurchased (shares):2,000,000 4.Originally determined repurchase price range (NTD):80.00~120.00 5.Actual period of the current repurchase:2026/02/25~2026/03/31 6.No.of shares currently repurchased (shares):2,000,000 7.Total monetary amount of shares currently repurchased (NTD):150,741,600 8.Current average

2026-03-18

Material Information- The Company was invited to attend the in-person and virtual institutional investor conference hosted by First Securities

1.Date of institutional investor conference:2026/04/14 2.Time of institutional investor conference:14:30 3.Location of institutional investor conference:2F., No. 35, Sec. 1, Chang’an E. Rd., Zhongshan Dist., Taipei City 4.Outline of institutional investor conference:(1)The Company was invited to attend the in-person and virtual institutional investor conference hosted by First Securities, to

2026-03-16

Material Information- Correction to the Material Information announced on March 12, 2026: Announcement of the newly appointed Chief Innovation Officer

1.Type of personnel changed (please enter: spokesperson, acting spokesperson, important personnel (CEO, COO, CMO, CSO, etc.), financial officer, accounting officer, corporate governance officer, chief information security officer, research and development officer, internal audit officer, or designated and non-designated representatives):Chief Innovation Officer 2.Date of occurrence of the

2026-03-12